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Unicentric epithelioid
hemangioendothelioma of the calcaneus: a case
report and review of literature
Mark C. Plumby1, Patrick Bacaj2 and Brock A. Lindsey1*

Abstract
Background: This review of the literature combined with a clinical case will allow the illustration of a favorable
outcome of this variable low grade malignancy, display a role for limb salvage surgery with intralesional treatment, and
offer a clinical example of epithelioid hemangioendothelioma, a rare malignancy.
Case presentation: The case report presents a case of solitary epithelioid hemangioendothelioma (EHE) of the
calcaneus in a 60-year-old male. Primary vascular tumors of the bone are rare; however, EHE is one of the most common primary malignant vascular tumors to occur in bone. A review of the literature found few cases that involved
the calcaneus; those cases found that involved the calcaneus were either part of a multifocal or metastatic disease
process. Our case presents a 45-month clinical follow-up of solitary EHE in the calcaneus treated with surgical excision
by curettage and cementing.
Conclusion: This case has clinical follow-up greater than 2 years post-operatively and could be a guide for treatment
of a rare disorder with a substantial paucity of literature.
Keywords: Hemangioendothelioma, Epithelioid, Angiosarcoma, Vascular tumor
Background
Most lytic lesions of bone are a result of metastatic disease; primary bone tumors are far more uncommon.
Benign primary bone entities are more common than
their malignant counterparts. It was estimated that the
age adjusted incidence rate for all bone and joint malignancies is 0.9 per 100,000 persons/year [1]. Epithelioid hemangioendothelioma (EHE) is a vascular tumor
that has a propensity to occur in bone. Among vascular tumors, it is considered a low grade malignancy,
between hemangioma and angiosarcoma [2–6]. The low
prevalence for primary malignant bone tumors, and thus
vascular tumors of bone, has limited the extent of our
knowledge. However, there has been much work over the
last few decades to help adequately identify and classify
EHE and its family of vascular tumors [6–13].
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EHE was given its name by Weiss and Enzinger in 1982
to reflect that it is neither completely benign nor fully
malignant [7]. More recently, it has been said that it is the
most common malignant vascular tumor of bone, though
still relatively rare, accounting for less than 1% of all bone
tumors. It has an overall prognosis that favors survival
[13]. EHE has been shown to occur slightly more in males
[7, 13] and at any age with a peak in the second and third
decades of life [4]. The majority of cases have been shown
to occur in the lower extremities, primarily the tibia and
femur [4, 7, 9, 13]. The most common complaint is local
pain at the site of the lesion. Radiographic imaging typically shows a lytic lesion; diagnosis is made with a biopsy
and study of the histopathological and immunohistochemical features.
To date, there have been no reports of solitary EHE
in the calcaneus. There are a few cases that show the
involvement of the calcaneus, all of which occurred in a
multifocal or metastatic setting [5, 14–17]. In this case
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report, we describe a solitary EHE of the calcaneus that
did not appear on initial radiographic imaging.

Case presentation
A 60-year-old male was evaluated for insidious onset
of right foot pain over 4 months, made worse by walking and standing. Radiographs at an outside facility were
reportedly normal. Two corticosteroid injections into
the sinus tarsus provided no relief. Upon referral new
radiographs were obtained (Fig. 1). Magnetic resonance
imaging (MRI) showed a complex lesion in the anterior
calcaneus with some surrounding edema and potential
concern for cortical disruption (Figs. 2, 3). A computed
tomography (CT) guided biopsy of the cyst showed a
lytic destructive lesion within the central and anterior
process of the calcaneus. There was cortical destruction along multiple sites at the margins of the lesion and
slight scattered calcifications (Fig. 4). The pathologic
report revealed cords and clusters of epithelioid cells and
foci of spindle cells in a myxochondroid matrix (Figs. 5,
6). Some of the epithelioid cells contained vacuoles and
rare erythrocyte (Fig. 7). Immunohistochemical stains
identified CD31, CD34, and CAMTA1 (Figs. 8, 9). Mixed
cytokeratin stain (MCK) showed very focal and equivocal staining and D2-40 and epithelial membrane antigen (EMA) were negative. There was extensive necrosis
and some spindling but no invasion of the surrounding
bone. These findings supported a diagnosis of epithelioid
hemangioendothelioma.
The patient was referred to our orthopaedic clinic
roughly 6 months after initial presentation. The right
lower extremity was neurovascularly intact with no
swelling, masses, or skin lesions. There was mild tenderness to palpation of the calcaneus and no palpable
nodes in the popliteal or inguinal regions. At this time,
radiographs showed a significant cystic lesion with

Fig. 1 Pre-operative radiograph of large lytic lesion in the calcaneus

Fig. 2 Preoperative sagittal T1 image of the calcaneus showing solid
lesion with fairly homogenous signal

Fig. 3 Preoperative sagittal T2 image with some heterogeneity
within the lesion surrounding bony edema, sclerotic border around
the lesion, but with concern for cortical breakthrough in the subtalar
joint

cortical breakthrough and no evidence of collapse. Routine bloodwork was normal. Positron emission tomography/computed tomography (PET/CT) ruled out proximal
metastasis; however, bilateral hilar and mediastinal adenopathy were reported along with increased signal in the
stomach and bilateral parotid glands.
The patient was taken to the operating room for excision and curettage with argon beam followed by cement
filling of the lesion and percutaneous pinning. A biopsy
taken during surgery showed the tumor to be histologically the same as the previous biopsy, but now involving
the surrounding bone. A thorough oncology and pulmonary workup for the mediastinal adenopathy ruled
out metastatic disease, as a biopsy showed a benign
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Fig. 4 Axial CT scan of lesion preoperatively displaying concern for
cortical destruction

Fig. 7 H&E ×600. The vacuoles represent attempts at blood vessel
formation and may contain red blood cell fragments

anthracotic lymph node with marked histiocytosis. The
patient returned to weight bearing activity at 3 months
and work after 6 months. CT scan and radiographs of the
hindfoot at his 6 month and 3 year follow-up showed well
fixed hardware without recurrence (Fig. 10). PET scan
at 3 years illustrated stable hilar lymphadenopathy and
absence of enhancement of the calcaneus. Other than
tolerable pain with extended walking, the patient has
made full and tumor free recovery at 3 years.
Fig. 5 H&E ×200. The tumor consists of large epithelioid and spindle
cells arranged in cords, clusters and as single cells within a myxoid to
hyalinized stroma

Fig. 6 H&E ×400. The tumor cells have moderately abundant eosinophilic cytoplasm with occasional cytoplasmic vacuoles. Nuclei are
round with prominent nucleoli

Discussion and conclusions
The majority of EHE cases of the bone occur in the lower
extremities, followed by the spine [13]. The most common locations in the lower extremity for EHE to occur,
in descending order, are the femur, tibia, fibula, and small
bones of the feet [4]. Review of the current literature
found four cases where the calcaneus was involved; however, none were unicentric. A case presented by Bisbinas
et al. [14] described multicentric EHE of the foot and
ankle in a 41-year-old male who presented with left foot
and ankle pain. Plain radiographs showed multiple osteolytic lesions in the left lower extremity and CT showed
no visceral involvement. The patient underwent excision
and curettage of all lesions except for one that involved
a rib. Biopsy showed no features of malignancy and the
patient was alive with no further progression at 5.5 years.
The second case, reported by Liu et al. [5], described
another multicentric presentation of EHE in the same
lower extremity. The patient was a 59-year-old female
who presented with swelling, pain, and functional deficits of her left lower leg. Physical examination demonstrated a 2.0 cm mass on the posterolateral aspect of the
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Fig. 8 CAMTA1 immunohistochemical stain, ×200. Tumor cell nuclei
stain positively with antibody to CAMTA1 protein, a fusion protein
unique to this tumor

Fig. 9 CD34 immunohistochemical stain, ×200. Tumor cells stain
positively for endothelial marker CD34. This stain also highlights the
anastomosing cord-like architecture of the tumor which recapitulates
the formation of primitive blood vessels

proximal lower leg and radiographs illustrated osteolytic
lesions. CT showed involvement of the proximal fibula,
distal tibia, cuneiform bone, and calcaneus. The patient
was treated with fibular head resection and curettage
of all other lower extremity lesions, followed by chemical cautery with a phenol solution. There was no local
recurrence at 28 months after surgery and no evidence of
internal metastasis.
A case report of a 17-year-old male illustrated another
multicentric involvement of the lower extremity [18]. This
young man presented with persistent pain of his right
ankle and radiographs showed multiple bony lesions of
the right lower extremity. CT identified lesions in the distal tibia, talus, calcaneus, and first cuneiform with some
calcifications. The diagnosis of EHE was established with

Page 4 of 6

open biopsy and the patient received radiation therapy of
4600 cGY. No follow-up was reported.
The final case showed involvement of the calcaneus in
a 28-year-old woman who presented with a 3-month history of left heel pain made worse by walking [16]. Radiographic imaging revealed a “lytic polylobulated lesion in
the left calcaneus” which was not present on plain radiographs 2 months earlier. At a 3-month follow-up, the
lytic defect showed slight expansion and an increase in
the sclerotic reaction of surrounding bone. CT showed
numerous small nodules in both lungs; however, there
were no correlative complaints. The patient received
adequate resection of the calcaneal lesion only. At 1 year
follow-up, CT and MRI showed five small asymptomatic
hepatic peripheral nodular lesions with no change in the
pulmonary lesions.
As illustrated in our case and the above case reports,
the most frequent clinical presentation of EHE of the
bone is local pain [6–9]. Swelling is less commonly noted
in the region of the lesion [9]. Radiographic imaging typically shows lytic lesions with a mix of features including surrounding sclerosis [4, 9], cortical destruction and
expansion [4, 8, 9], and soft tissue expansion [4, 6, 8, 9];
however, there are no pathognomonic features that can
be used to make the diagnosis. It is interesting to note the
lack of radiographic evidence upon initial presentation in
our case and in the aforementioned 28-year-old female,
despite the presence of symptoms persisting greater than
2 months illustrating the variable nature of the malignancy. Clinically, these patients presented with an indolent clinical course; however, the rapid progression over a
few months from negative radiographic identification to
prominent lytic lesions suggests a rapid cellular development of the malignancy.
Microscopically, these lesions arise from vessels by
expanding the vessel in a centrifugal pattern from the
lumen extending outward into soft tissue [3, 7]. It has
been shown that the majority of cases of EHE arise from
veins [3, 7]. The tumor consists of round or cuboid epithelioid endothelial cells with abundant eosinophilic
cytoplasm [9] embedded in a loose, lightly basophilic
myxoid background [8]. In most cases, there is virtually
no mitotic activity. In roughly one quarter of the cases,
the “tumor contains areas with significant atypical,
mitotic activity (more than 1 mitosis per 10 High Power
Field), focal spindling, or necrosis” [3]. The most characteristic feature is the presence of intracytoplasmic vacuoles reminiscent of primitive lumen formation that may
contain erythrocytes [4, 8]. This characteristic helps to
distinguish it from epithelioid hemangioma and angiosarcoma, as each display well-formed vascular channels
[8]. Immunohistochemical staining for CD31, CD34,
vimentin, and FLI-1 help identify the vascular origin as
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been shown to occur in up to 31% of cases and is more
common in those with marked cellular atypia, increased
mitotic activity, spindling and necrosis [3, 4].
Complete and wide local excision is the proposed
method of treatment [3–6, 9, 13]. Chemotherapy has
been used for multifocal and metastatic cases [4, 5,
11–13] and radiation therapy alone or as an adjuvant has been successful in multicentric cases [4–6, 9,
13]. Although radiation can be successful, it should be
reserved for cases not amenable to surgery as it has been
shown to induce osteosarcoma [13].
Fig. 10 Two-year post-operative follow-up radiograph of the calcaneus showing curettage and cementing with Steinman pin reinforcement. There has been so sign of recurrence of disease or failure of the
construct despite full activity

the tumor can often be mistaken for metastatic carcinoma [7, 9].
Often the histological features can deviate from what
is typical and show a solid growth pattern, epithelioid
change, or spindle cell morphology. These changes
can complicate the diagnosis. In 2012, Errani et al. [6]
reported molecular analysis of 17 cases of EHE at different anatomical locations. They found an “identical
genetic translocation [t(1, 3)(1p36.23;3q25.1)] involving
the CAMTA1 and WWTR1 genes on chromosomes 1
and 3, respectively”. In 2014, Flucke et al. [12] identified
the WWTR-1CAMTA1 fusion gene in 33 of 35 cases of
varying anatomical EHE. The remaining two cases were
found to contain a second fusion protein, YAP1-TFE3.
All cases were identified using either fluorescent in situ
hybridization (FISH) and/or reverse transcriptase-polymerase chain reaction (RT-PCR) [12].
There have been no predisposing factors identified
[3]. Despite the variable nature of EHE, overall survival
is high. In 1996, Kleer et al. [9] reported an overall survival of 89% for unicentric disease and 50% for multifocal
disease. In a study of EHE in 62 patients in 2014, Angelini et al. found that 97% with unicentric disease lived to
10 years compared to 74% with multifocal disease [13].
From their study, Angelini et al. encourage using the type
of presentation (unicentric vs. multifocal) in conjunction
with degree of differentiation of histological features to
determine prognosis [13]. Other studies state that atypical histological features (mitotic activity greater than
3/50 per high power field) and tumor size greater than
3 cm, regardless of anatomical location, have a higher
rate of mortality [12, 19]. However, 10–15% of cases
with histologically “benign appearing EHE metastasize
and cause the death of the patient” [3]. Metastasis has
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